CVE-2020-3552

Cisco Aironet Access Points Ethernet Wired Clients Denial of Service Vulnerability

Description

A vulnerability in the Ethernet packet handling of Cisco Aironet Access Points (APs) Software could allow an unauthenticated, adjacent attacker to cause a denial of service (DoS) condition on an affected device. The vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by connecting as a wired client to the Ethernet interface of an affected device and sending a series of specific packets within a short time frame. A successful exploit could allow the attacker to cause a NULL pointer access that results in a reload of the affected device.

Category

7.4
CVSS
Severity: High
CVSS 3.1 •
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.10%
Vendor Advisory cisco.com
Affected: Cisco Cisco Aironet Access Point Software
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2020-3552?
CVE-2020-3552 has been scored as a high severity vulnerability.
How to fix CVE-2020-3552?
To fix CVE-2020-3552, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2020-3552 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2020-3552 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2020-3552?
CVE-2020-3552 affects Cisco Cisco Aironet Access Point Software.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.